Global Endometriosis Drugs Market Research Report 2018 Opportunities, Size, Cost Structure, Service Provider, Segmentation, Shares, Forecast to 2024

Request for a SAMPLE REPORT

Fill up your details below and get the sample report for FREE

 Published Date : Aug-2018   |    Format :PDF   |    Number of Pages : 113
This report studies the global Endometriosis Drugs market status and forecast, categorizes the global Endometriosis Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Endometriosis affects an estimated 1 in 10 women in the reproductive age group of 15-49 years.
Among these therapies, Elagolix, a first-in-class GnRH receptor antagonist, is closest to market. 
The global Endometriosis Drugs market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

The major players covered in this report
    AbbVie
    Astellas Pharma
    AstraZeneca
    Debiopharm Group
    Evotec AG
    Kissei Pharmaceutical
    Neurocrine Biosciences
    ObsEva
    Pfizer
    Repros Therapeutics
    Roivant Sciences GmbH
    Takeda Pharmaceutical Company Limited
    ValiRx

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
    United States
    Europe
    China
    Japan
    Southeast Asia
    India

We can also provide the customized separate regional or country-level reports, for the following regions:
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Rest of Asia-Pacific
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
        Rest of Europe
    Central & South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Saudi Arabia
        Turkey
        Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Hormonal Therapy
    Add-back Medication
    Progestogens
    Chinese Herbs
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospitals
    Clinics
    Research Institutes

The study objectives of this report are:
    To analyze and study the global Endometriosis Drugs sales, value, status (2013-2017) and forecast (2018-2025);
    To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
    Focuses on the key Endometriosis Drugs players, to study the sales, value, market share and development plans in future.
    Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
    To define, describe and forecast the market by type, application and region.
    To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
    To identify significant trends and factors driving or inhibiting the market growth.
    To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
    To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Endometriosis Drugs are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Endometriosis Drugs Manufacturers
Endometriosis Drugs Distributors/Traders/Wholesalers
Endometriosis Drugs Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Endometriosis Drugs market, by end-use.
Detailed analysis and profiles of additional market players.

Global Endometriosis Drugs Sales Market Report 2018
1 Endometriosis Drugs Market Overview
    1.1 Product Overview and Scope of Endometriosis Drugs
    1.2 Classification of Endometriosis Drugs by Product Category
        1.2.1 Global Endometriosis Drugs Market Size (Sales) Comparison by Type (2013-2025)
        1.2.2 Global Endometriosis Drugs Market Size (Sales) Market Share by Type (Product Category) in 2017
        1.2.3 Hormonal Therapy
        1.2.4 Add-back Medication
        1.2.5 Progestogens
        1.2.6 Chinese Herbs
    1.3 Global Endometriosis Drugs Market by Application/End Users
        1.3.1 Global Endometriosis Drugs Sales (Volume) and Market Share Comparison by Application (2013-2025)
        1.3.1 Hospitals
        1.3.2 Clinics
        1.3.3 Research Institutes
    1.4 Global Endometriosis Drugs Market by Region
        1.4.1 Global Endometriosis Drugs Market Size (Value) Comparison by Region (2013-2025)
        1.4.2 United States Endometriosis Drugs Status and Prospect (2013-2025)
        1.4.3 Europe Endometriosis Drugs Status and Prospect (2013-2025)
        1.4.4 China Endometriosis Drugs Status and Prospect (2013-2025)
        1.4.5 Japan Endometriosis Drugs Status and Prospect (2013-2025)
        1.4.6 Southeast Asia Endometriosis Drugs Status and Prospect (2013-2025)
        1.4.7 India Endometriosis Drugs Status and Prospect (2013-2025)
    1.5 Global Market Size (Value and Volume) of Endometriosis Drugs (2013-2025)
        1.5.1 Global Endometriosis Drugs Sales and Growth Rate (2013-2025)
        1.5.2 Global Endometriosis Drugs Revenue and Growth Rate (2013-2025)

2 Global Endometriosis Drugs Competition by Players/Suppliers, Type and Application
     2.1 Global Endometriosis Drugs Market Competition by Players/Suppliers
        2.1.1 Global Endometriosis Drugs Sales and Market Share of Key Players/Suppliers (2013-2018)
        2.1.2 Global Endometriosis Drugs Revenue and Share by Players/Suppliers (2013-2018)
    2.2 Global Endometriosis Drugs (Volume and Value) by Type
        2.2.1 Global Endometriosis Drugs Sales and Market Share by Type (2013-2018)
        2.2.2 Global Endometriosis Drugs Revenue and Market Share by Type (2013-2018)
    2.3 Global Endometriosis Drugs (Volume and Value) by Region
        2.3.1 Global Endometriosis Drugs Sales and Market Share by Region (2013-2018)
        2.3.2 Global Endometriosis Drugs Revenue and Market Share by Region (2013-2018)
    2.4 Global Endometriosis Drugs (Volume) by Application

3 United States Endometriosis Drugs (Volume, Value and Sales Price)
    3.1 United States Endometriosis Drugs Sales and Value (2013-2018)
        3.1.1 United States Endometriosis Drugs Sales and Growth Rate (2013-2018)
        3.1.2 United States Endometriosis Drugs Revenue and Growth Rate (2013-2018)
        3.1.3 United States Endometriosis Drugs Sales Price Trend (2013-2018)
    3.2 United States Endometriosis Drugs Sales Volume and Market Share by Players (2013-2018)
    3.3 United States Endometriosis Drugs Sales Volume and Market Share by Type (2013-2018)
    3.4 United States Endometriosis Drugs Sales Volume and Market Share by Application (2013-2018)

4 Europe Endometriosis Drugs (Volume, Value and Sales Price)
    4.1 Europe Endometriosis Drugs Sales and Value (2013-2018)
        4.1.1 Europe Endometriosis Drugs Sales and Growth Rate (2013-2018)
        4.1.2 Europe Endometriosis Drugs Revenue and Growth Rate (2013-2018)
        4.1.3 Europe Endometriosis Drugs Sales Price Trend (2013-2018)
    4.2 Europe Endometriosis Drugs Sales Volume and Market Share by Players (2013-2018)
    4.3 Europe Endometriosis Drugs Sales Volume and Market Share by Type (2013-2018)
    4.4 Europe Endometriosis Drugs Sales Volume and Market Share by Application (2013-2018)

5 China Endometriosis Drugs (Volume, Value and Sales Price)
    5.1 China Endometriosis Drugs Sales and Value (2013-2018)
        5.1.1 China Endometriosis Drugs Sales and Growth Rate (2013-2018)
        5.1.2 China Endometriosis Drugs Revenue and Growth Rate (2013-2018)
        5.1.3 China Endometriosis Drugs Sales Price Trend (2013-2018)
    5.2 China Endometriosis Drugs Sales Volume and Market Share by Players (2013-2018)
    5.3 China Endometriosis Drugs Sales Volume and Market Share by Type (2013-2018)
    5.4 China Endometriosis Drugs Sales Volume and Market Share by Application (2013-2018)

6 Japan Endometriosis Drugs (Volume, Value and Sales Price)
    6.1 Japan Endometriosis Drugs Sales and Value (2013-2018)
        6.1.1 Japan Endometriosis Drugs Sales and Growth Rate (2013-2018)
        6.1.2 Japan Endometriosis Drugs Revenue and Growth Rate (2013-2018)
        6.1.3 Japan Endometriosis Drugs Sales Price Trend (2013-2018)
    6.2 Japan Endometriosis Drugs Sales Volume and Market Share by Players (2013-2018)
    6.3 Japan Endometriosis Drugs Sales Volume and Market Share by Type (2013-2018)
    6.4 Japan Endometriosis Drugs Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Endometriosis Drugs (Volume, Value and Sales Price)
    7.1 Southeast Asia Endometriosis Drugs Sales and Value (2013-2018)
        7.1.1 Southeast Asia Endometriosis Drugs Sales and Growth Rate (2013-2018)
        7.1.2 Southeast Asia Endometriosis Drugs Revenue and Growth Rate (2013-2018)
        7.1.3 Southeast Asia Endometriosis Drugs Sales Price Trend (2013-2018)
    7.2 Southeast Asia Endometriosis Drugs Sales Volume and Market Share by Players (2013-2018)
    7.3 Southeast Asia Endometriosis Drugs Sales Volume and Market Share by Type (2013-2018)
    7.4 Southeast Asia Endometriosis Drugs Sales Volume and Market Share by Application (2013-2018)

8 India Endometriosis Drugs (Volume, Value and Sales Price)
    8.1 India Endometriosis Drugs Sales and Value (2013-2018)
        8.1.1 India Endometriosis Drugs Sales and Growth Rate (2013-2018)
        8.1.2 India Endometriosis Drugs Revenue and Growth Rate (2013-2018)
        8.1.3 India Endometriosis Drugs Sales Price Trend (2013-2018)
    8.2 India Endometriosis Drugs Sales Volume and Market Share by Players (2013-2018)
    8.3 India Endometriosis Drugs Sales Volume and Market Share by Type (2013-2018)
    8.4 India Endometriosis Drugs Sales Volume and Market Share by Application (2013-2018)

9 Global Endometriosis Drugs Players/Suppliers Profiles and Sales Data
    9.1 AbbVie
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Endometriosis Drugs Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 AbbVie Endometriosis Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
        9.1.4 Main Business/Business Overview
    9.2 Astellas Pharma
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Endometriosis Drugs Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 Astellas Pharma Endometriosis Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
        9.2.4 Main Business/Business Overview
    9.3 AstraZeneca
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Endometriosis Drugs Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 AstraZeneca Endometriosis Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
        9.3.4 Main Business/Business Overview
    9.4 Debiopharm Group
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Endometriosis Drugs Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 Debiopharm Group Endometriosis Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
        9.4.4 Main Business/Business Overview
    9.5 Evotec AG
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 Endometriosis Drugs Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 Evotec AG Endometriosis Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
        9.5.4 Main Business/Business Overview
    9.6 Kissei Pharmaceutical
        9.6.1 Company Basic Information, Manufacturing Base and Competitors
        9.6.2 Endometriosis Drugs Product Category, Application and Specification
            9.6.2.1 Product A
            9.6.2.2 Product B
        9.6.3 Kissei Pharmaceutical Endometriosis Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
        9.6.4 Main Business/Business Overview
    9.7 Neurocrine Biosciences
        9.7.1 Company Basic Information, Manufacturing Base and Competitors
        9.7.2 Endometriosis Drugs Product Category, Application and Specification
            9.7.2.1 Product A
            9.7.2.2 Product B
        9.7.3 Neurocrine Biosciences Endometriosis Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
        9.7.4 Main Business/Business Overview
    9.8 ObsEva
        9.8.1 Company Basic Information, Manufacturing Base and Competitors
        9.8.2 Endometriosis Drugs Product Category, Application and Specification
            9.8.2.1 Product A
            9.8.2.2 Product B
        9.8.3 ObsEva Endometriosis Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
        9.8.4 Main Business/Business Overview
    9.9 Pfizer
        9.9.1 Company Basic Information, Manufacturing Base and Competitors
        9.9.2 Endometriosis Drugs Product Category, Application and Specification
            9.9.2.1 Product A
            9.9.2.2 Product B
        9.9.3 Pfizer Endometriosis Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
        9.9.4 Main Business/Business Overview
    9.10 Repros Therapeutics
        9.10.1 Company Basic Information, Manufacturing Base and Competitors
        9.10.2 Endometriosis Drugs Product Category, Application and Specification
            9.10.2.1 Product A
            9.10.2.2 Product B
        9.10.3 Repros Therapeutics Endometriosis Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
        9.10.4 Main Business/Business Overview
    9.11 Roivant Sciences GmbH
    9.12 Takeda Pharmaceutical Company Limited
    9.13 ValiRx

10 Endometriosis Drugs Maufacturing Cost Analysis
    10.1 Endometriosis Drugs Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Endometriosis Drugs
    10.3 Manufacturing Process Analysis of Endometriosis Drugs

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Endometriosis Drugs Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Endometriosis Drugs Major Manufacturers in 2017
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Endometriosis Drugs Market Forecast (2018-2025)
    14.1 Global Endometriosis Drugs Sales Volume, Revenue and Price Forecast (2018-2025)
       14.1.1 Global Endometriosis Drugs Sales Volume and Growth Rate Forecast (2018-2025)
       14.1.2 Global Endometriosis Drugs Revenue and Growth Rate Forecast (2018-2025)
       14.1.3 Global Endometriosis Drugs Price and Trend Forecast (2018-2025)
    14.2 Global Endometriosis Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
       14.2.1 Global Endometriosis Drugs Sales Volume and Growth Rate Forecast by Regions (2018-2025)
       14.2.2 Global Endometriosis Drugs Revenue and Growth Rate Forecast by Regions (2018-2025)
       14.2.3 United States Endometriosis Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
       14.2.4 Europe Endometriosis Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
       14.2.5 China Endometriosis Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
       14.2.6 Japan Endometriosis Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
       14.2.7 Southeast Asia Endometriosis Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
       14.2.8 India Endometriosis Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
    14.3 Global Endometriosis Drugs Sales Volume, Revenue and Price Forecast by Type (2018-2025)
       14.3.1 Global Endometriosis Drugs Sales Forecast by Type (2018-2025)
       14.3.2 Global Endometriosis Drugs Revenue Forecast by Type (2018-2025)
       14.3.3 Global Endometriosis Drugs Price Forecast by Type (2018-2025)
    14.4 Global Endometriosis Drugs Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology/Research Approach
        16.1.1 Research Programs/Design
        16.1.2 Market Size Estimation
        16.1.3 Market Breakdown and Data Triangulation
    16.2 Data Source
        16.2.1 Secondary Sources
        16.2.2 Primary Sources
    16.3 Disclaimer



List of Tables and Figures

    Figure Product Picture of Endometriosis Drugs
    Figure Global Endometriosis Drugs Sales Volume Comparison (K Units) by Type (2013-2025)
    Figure Global Endometriosis Drugs Sales Volume Market Share by Type (Product Category) in 2017
    Figure Hormonal Therapy Product Picture
    Figure Add-back Medication Product Picture
    Figure Progestogens Product Picture
    Figure Chinese Herbs Product Picture
    Figure Global Endometriosis Drugs Sales Comparison (K Units) by Application (2013-2025)
    Figure Global Sales Market Share of Endometriosis Drugs by Application in 2017
    Figure Hospitals Examples
    Table Key Downstream Customer in Hospitals
    Figure Clinics Examples
    Table Key Downstream Customer in Clinics
    Figure Research Institutes Examples
    Table Key Downstream Customer in Research Institutes
    Figure Global Endometriosis Drugs Market Size (Million USD) by Regions (2013-2025)
    Figure United States Endometriosis Drugs Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Europe Endometriosis Drugs Revenue (Million USD) and Growth Rate (2013-2025)
    Figure China Endometriosis Drugs Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Japan Endometriosis Drugs Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Southeast Asia Endometriosis Drugs Revenue (Million USD) and Growth Rate (2013-2025)
    Figure India Endometriosis Drugs Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Global Endometriosis Drugs Sales Volume (K Units) and Growth Rate (2013-2025)
    Figure Global Endometriosis Drugs Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Global Market Major Players Endometriosis Drugs Sales Volume (K Units) (2013-2018)
    Table Global Endometriosis Drugs Sales (K Units) of Key Players/Suppliers (2013-2018)
    Table Global Endometriosis Drugs Sales Share by Players/Suppliers (2013-2018)
    Figure 2017 Endometriosis Drugs Sales Share by Players/Suppliers
    Figure 2017 Endometriosis Drugs Sales Share by Players/Suppliers
    Figure Global Endometriosis Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
    Table Global Endometriosis Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
    Table Global Endometriosis Drugs Revenue Share by Players/Suppliers (2013-2018)
    Table 2017 Global Endometriosis Drugs Revenue Share by Players
    Table 2017 Global Endometriosis Drugs Revenue Share by Players
    Table Global Endometriosis Drugs Sales (K Units) and Market Share by Type (2013-2018)
    Table Global Endometriosis Drugs Sales Share (K Units) by Type (2013-2018)
    Figure Sales Market Share of Endometriosis Drugs by Type (2013-2018)
    Figure Global Endometriosis Drugs Sales Growth Rate by Type (2013-2018)
    Table Global Endometriosis Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
    Table Global Endometriosis Drugs Revenue Share by Type (2013-2018)
    Figure Revenue Market Share of Endometriosis Drugs by Type (2013-2018)
    Figure Global Endometriosis Drugs Revenue Growth Rate by Type (2013-2018)
    Table Global Endometriosis Drugs Sales Volume (K Units) and Market Share by Region (2013-2018)
    Table Global Endometriosis Drugs Sales Share by Region (2013-2018)
    Figure Sales Market Share of Endometriosis Drugs by Region (2013-2018)
    Figure Global Endometriosis Drugs Sales Growth Rate by Region in 2017
    Table Global Endometriosis Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
    Table Global Endometriosis Drugs Revenue Share (%) by Region (2013-2018)
    Figure Revenue Market Share of Endometriosis Drugs by Region (2013-2018)
    Figure Global Endometriosis Drugs Revenue Growth Rate by Region in 2017
    Table Global Endometriosis Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
    Table Global Endometriosis Drugs Revenue Share (%) by Region (2013-2018)
    Figure Revenue Market Share of Endometriosis Drugs by Region (2013-2018)
    Figure Global Endometriosis Drugs Revenue Market Share by Region in 2017
    Table Global Endometriosis Drugs Sales Volume (K Units) and Market Share by Application (2013-2018)
    Table Global Endometriosis Drugs Sales Share (%) by Application (2013-2018)
    Figure Sales Market Share of Endometriosis Drugs by Application (2013-2018)
    Figure Global Endometriosis Drugs Sales Market Share by Application (2013-2018)
    Figure United States Endometriosis Drugs Sales (K Units) and Growth Rate (2013-2018)
    Figure United States Endometriosis Drugs Revenue (Million USD) and Growth Rate (2013-2018)
    Figure United States Endometriosis Drugs Sales Price (USD/Unit) Trend (2013-2018)
    Table United States Endometriosis Drugs Sales Volume (K Units) by Players (2013-2018)
    Table United States Endometriosis Drugs Sales Volume Market Share by Players (2013-2018)
    Figure United States Endometriosis Drugs Sales Volume Market Share by Players in 2017
    Table United States Endometriosis Drugs Sales Volume (K Units) by Type (2013-2018)
    Table United States Endometriosis Drugs Sales Volume Market Share by Type (2013-2018)
    Figure United States Endometriosis Drugs Sales Volume Market Share by Type in 2017
    Table United States Endometriosis Drugs Sales Volume (K Units) by Application (2013-2018)
    Table United States Endometriosis Drugs Sales Volume Market Share by Application (2013-2018)
    Figure United States Endometriosis Drugs Sales Volume Market Share by Application in 2017
    Figure Europe Endometriosis Drugs Sales (K Units) and Growth Rate (2013-2018)
    Figure Europe Endometriosis Drugs Revenue (Million USD) and Growth Rate (2013-2018)
    Figure Europe Endometriosis Drugs Sales Price (USD/Unit) Trend (2013-2018)
    Table Europe Endometriosis Drugs Sales Volume (K Units) by Players (2013-2018)
    Table Europe Endometriosis Drugs Sales Volume Market Share by Players (2013-2018)
    Figure Europe Endometriosis Drugs Sales Volume Market Share by Players in 2017
    Table Europe Endometriosis Drugs Sales Volume (K Units) by Type (2013-2018)
    Table Europe Endometriosis Drugs Sales Volume Market Share by Type (2013-2018)
    Figure Europe Endometriosis Drugs Sales Volume Market Share by Type in 2017
    Table Europe Endometriosis Drugs Sales Volume (K Units) by Application (2013-2018)
    Table Europe Endometriosis Drugs Sales Volume Market Share by Application (2013-2018)
    Figure Europe Endometriosis Drugs Sales Volume Market Share by Application in 2017
    Figure China Endometriosis Drugs Sales (K Units) and Growth Rate (2013-2018)
    Figure China Endometriosis Drugs Revenue (Million USD) and Growth Rate (2013-2018)
    Figure China Endometriosis Drugs Sales Price (USD/Unit) Trend (2013-2018)
    Table China Endometriosis Drugs Sales Volume (K Units) by Players (2013-2018)
    Table China Endometriosis Drugs Sales Volume Market Share by Players (2013-2018)
    Figure China Endometriosis Drugs Sales Volume Market Share by Players in 2017
    Table China Endometriosis Drugs Sales Volume (K Units) by Type (2013-2018)
    Table China Endometriosis Drugs Sales Volume Market Share by Type (2013-2018)
    Figure China Endometriosis Drugs Sales Volume Market Share by Type in 2017
    Table China Endometriosis Drugs Sales Volume (K Units) by Application (2013-2018)
    Table China Endometriosis Drugs Sales Volume Market Share by Application (2013-2018)
    Figure China Endometriosis Drugs Sales Volume Market Share by Application in 2017
    Figure Japan Endometriosis Drugs Sales (K Units) and Growth Rate (2013-2018)
    Figure Japan Endometriosis Drugs Revenue (Million USD) and Growth Rate (2013-2018)
    Figure Japan Endometriosis Drugs Sales Price (USD/Unit) Trend (2013-2018)
    Table Japan Endometriosis Drugs Sales Volume (K Units) by Players (2013-2018)
    Table Japan Endometriosis Drugs Sales Volume Market Share by Players (2013-2018)
    Figure Japan Endometriosis Drugs Sales Volume Market Share by Players in 2017
    Table Japan Endometriosis Drugs Sales Volume (K Units) by Type (2013-2018)
    Table Japan Endometriosis Drugs Sales Volume Market Share by Type (2013-2018)
    Figure Japan Endometriosis Drugs Sales Volume Market Share by Type in 2017
    Table Japan Endometriosis Drugs Sales Volume (K Units) by Application (2013-2018)
    Table Japan Endometriosis Drugs Sales Volume Market Share by Application (2013-2018)
    Figure Japan Endometriosis Drugs Sales Volume Market Share by Application in 2017
    Figure Southeast Asia Endometriosis Drugs Sales (K Units) and Growth Rate (2013-2018)
    Figure Southeast Asia Endometriosis Drugs Revenue (Million USD) and Growth Rate (2013-2018)
    Figure Southeast Asia Endometriosis Drugs Sales Price (USD/Unit) Trend (2013-2018)
    Table Southeast Asia Endometriosis Drugs Sales Volume (K Units) by Players (2013-2018)
    Table Southeast Asia Endometriosis Drugs Sales Volume Market Share by Players (2013-2018)
    Figure Southeast Asia Endometriosis Drugs Sales Volume Market Share by Players in 2017
    Table Southeast Asia Endometriosis Drugs Sales Volume (K Units) by Type (2013-2018)
    Table Southeast Asia Endometriosis Drugs Sales Volume Market Share by Type (2013-2018)
    Figure Southeast Asia Endometriosis Drugs Sales Volume Market Share by Type in 2017
    Table Southeast Asia Endometriosis Drugs Sales Volume (K Units) by Application (2013-2018)
    Table Southeast Asia Endometriosis Drugs Sales Volume Market Share by Application (2013-2018)
    Figure Southeast Asia Endometriosis Drugs Sales Volume Market Share by Application in 2017
    Figure India Endometriosis Drugs Sales (K Units) and Growth Rate (2013-2018)
    Figure India Endometriosis Drugs Revenue (Million USD) and Growth Rate (2013-2018)
    Figure India Endometriosis Drugs Sales Price (USD/Unit) Trend (2013-2018)
    Table India Endometriosis Drugs Sales Volume (K Units) by Players (2013-2018)
    Table India Endometriosis Drugs Sales Volume Market Share by Players (2013-2018)
    Figure India Endometriosis Drugs Sales Volume Market Share by Players in 2017
    Table India Endometriosis Drugs Sales Volume (K Units) by Type (2013-2018)
    Table India Endometriosis Drugs Sales Volume Market Share by Type (2013-2018)
    Figure India Endometriosis Drugs Sales Volume Market Share by Type in 2017
    Table India Endometriosis Drugs Sales Volume (K Units) by Application (2013-2018)
    Table India Endometriosis Drugs Sales Volume Market Share by Application (2013-2018)
    Figure India Endometriosis Drugs Sales Volume Market Share by Application in 2017
    Table AbbVie Basic Information List
    Table AbbVie Endometriosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure AbbVie Endometriosis Drugs Sales Growth Rate (2013-2018)
    Figure AbbVie Endometriosis Drugs Sales Global Market Share (2013-2018)
    Figure AbbVie Endometriosis Drugs Revenue Global Market Share (2013-2018)
    Table Astellas Pharma Basic Information List
    Table Astellas Pharma Endometriosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Astellas Pharma Endometriosis Drugs Sales Growth Rate (2013-2018)
    Figure Astellas Pharma Endometriosis Drugs Sales Global Market Share (2013-2018)
    Figure Astellas Pharma Endometriosis Drugs Revenue Global Market Share (2013-2018)
    Table AstraZeneca Basic Information List
    Table AstraZeneca Endometriosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure AstraZeneca Endometriosis Drugs Sales Growth Rate (2013-2018)
    Figure AstraZeneca Endometriosis Drugs Sales Global Market Share (2013-2018
    Figure AstraZeneca Endometriosis Drugs Revenue Global Market Share (2013-2018)
    Table Debiopharm Group Basic Information List
    Table Debiopharm Group Endometriosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Debiopharm Group Endometriosis Drugs Sales Growth Rate (2013-2018)
    Figure Debiopharm Group Endometriosis Drugs Sales Global Market Share (2013-2018)
    Figure Debiopharm Group Endometriosis Drugs Revenue Global Market Share (2013-2018)
    Table Evotec AG Basic Information List
    Table Evotec AG Endometriosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Evotec AG Endometriosis Drugs Sales Growth Rate (2013-2018)
    Figure Evotec AG Endometriosis Drugs Sales Global Market Share (2013-2018)
    Figure Evotec AG Endometriosis Drugs Revenue Global Market Share (2013-2018)
    Table Kissei Pharmaceutical Basic Information List
    Table Kissei Pharmaceutical Endometriosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Kissei Pharmaceutical Endometriosis Drugs Sales Growth Rate (2013-2018)
    Figure Kissei Pharmaceutical Endometriosis Drugs Sales Global Market Share (2013-2018
    Figure Kissei Pharmaceutical Endometriosis Drugs Revenue Global Market Share (2013-2018)
    Table Neurocrine Biosciences Basic Information List
    Table Neurocrine Biosciences Endometriosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Neurocrine Biosciences Endometriosis Drugs Sales Growth Rate (2013-2018)
    Figure Neurocrine Biosciences Endometriosis Drugs Sales Global Market Share (2013-2018)
    Figure Neurocrine Biosciences Endometriosis Drugs Revenue Global Market Share (2013-2018)
    Table ObsEva Basic Information List
    Table ObsEva Endometriosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure ObsEva Endometriosis Drugs Sales Growth Rate (2013-2018)
    Figure ObsEva Endometriosis Drugs Sales Global Market Share (2013-2018
    Figure ObsEva Endometriosis Drugs Revenue Global Market Share (2013-2018)
    Table Pfizer Basic Information List
    Table Pfizer Endometriosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Pfizer Endometriosis Drugs Sales Growth Rate (2013-2018)
    Figure Pfizer Endometriosis Drugs Sales Global Market Share (2013-2018)
    Figure Pfizer Endometriosis Drugs Revenue Global Market Share (2013-2018)
    Table Repros Therapeutics Basic Information List
    Table Repros Therapeutics Endometriosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Repros Therapeutics Endometriosis Drugs Sales Growth Rate (2013-2018)
    Figure Repros Therapeutics Endometriosis Drugs Sales Global Market Share (2013-2018)
    Figure Repros Therapeutics Endometriosis Drugs Revenue Global Market Share (2013-2018)
    Table Roivant Sciences GmbH Basic Information List
    Table Takeda Pharmaceutical Company Limited Basic Information List
    Table ValiRx Basic Information List
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Endometriosis Drugs
    Figure Manufacturing Process Analysis of Endometriosis Drugs
    Figure Endometriosis Drugs Industrial Chain Analysis
    Table Raw Materials Sources of Endometriosis Drugs Major Players in 2017
    Table Major Buyers of Endometriosis Drugs
    Table Distributors/Traders List
    Figure Global Endometriosis Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
    Figure Global Endometriosis Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure Global Endometriosis Drugs Price (USD/Unit) and Trend Forecast (2018-2025)
    Table Global Endometriosis Drugs Sales Volume (K Units) Forecast by Regions (2018-2025)
    Figure Global Endometriosis Drugs Sales Volume Market Share Forecast by Regions (2018-2025)
    Figure Global Endometriosis Drugs Sales Volume Market Share Forecast by Regions in 2025
    Table Global Endometriosis Drugs Revenue (Million USD) Forecast by Regions (2018-2025)
    Figure Global Endometriosis Drugs Revenue Market Share Forecast by Regions (2018-2025)
    Figure Global Endometriosis Drugs Revenue Market Share Forecast by Regions in 2025
    Figure United States Endometriosis Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
    Figure United States Endometriosis Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure Europe Endometriosis Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
    Figure Europe Endometriosis Drugs Revenue and Growth Rate Forecast (2018-2025)
    Figure China Endometriosis Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
    Figure China Endometriosis Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure Japan Endometriosis Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
    Figure Japan Endometriosis Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure Southeast Asia Endometriosis Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
    Figure Southeast Asia Endometriosis Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure India Endometriosis Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
    Figure India Endometriosis Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Table Global Endometriosis Drugs Sales (K Units) Forecast by Type (2018-2025)
    Figure Global Endometriosis Drugs Sales Volume Market Share Forecast by Type (2018-2025)
    Table Global Endometriosis Drugs Revenue (Million USD) Forecast by Type (2018-2025)
    Figure Global Endometriosis Drugs Revenue Market Share Forecast by Type (2018-2025)
    Table Global Endometriosis Drugs Price (USD/Unit) Forecast by Type (2018-2025)
    Table Global Endometriosis Drugs Sales (K Units) Forecast by Application (2018-2025)
    Figure Global Endometriosis Drugs Sales Market Share Forecast by Application (2018-2025)
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

Latest News

25-Feb-2019 | Medical Devices

Launch Of Symjepi Epinephrine Syringe To Boost The Syringe Market Growth In US

A rising burden of chronic diseases has been observed all across the world, which, in turn, has elevated the usage of syringes. Overall, the global syringe market is anticipated to observe vigorous ...

25-Feb-2019 | Electrical & Electronic Device

Launch Of Xiaomi Set-Top Box To Power The Global 4K Set-Top Box Market

While smart TVs are turning out to be much more widespread these days, a number of consumers still choose to opt for normal TVs and then employ smart streaming set top box with them. Popular choice ...

13-Feb-2019 | Software

Bioinspired Artificial Bug Eye Creation Is A Baton For Global Autonomous Car Market

After looking at the different eye lens structures of the animals and humans, the researchers have decided on creating a sharp image using its design. The compound eyes of the bugs are currently be ...

13-Feb-2019 | Consumer Goods & Retailing

Cafe X’s $12 Million “Seed-1” Round To Boost The Global Coffee Market

Cafe X, a company engaged in building robot baristas, is about to raise a $12 Million “Seed-1” round. Recently, Crunchbase News broke the story when it came across regulatory f ...

05-Feb-2019 | Chemicals & Materials

Clinically Produced Cells Change The Horizon Of Global Bone Cement And Glue Market

The group of researchers from the New York Stem Cell Foundation Research Institute published an article in Stem Cell Research and Therapy where the details regarding the clinical ...